# Outcomes in COVID-19 Patients with Acute Cholangitis: A Single-Center Retrospective Analysis

**Authors:** Deiana Vuletici, Bogdan Miutescu, Calin Burciu, Iulia Ratiu, Tudor Moga, Eyad Gadour, Alexandru Catalin Motofelea, Oana Koppandi, Roxana Sirli, Alina Popescu

PMC · DOI: 10.3390/medicina60081354 · 2024-08-20

## TL;DR

This study found that patients with acute cholangitis and COVID-19 had longer hospital stays and different infection patterns compared to those without COVID-19.

## Contribution

The study provides new insights into how COVID-19 affects outcomes and microbial profiles in acute cholangitis patients.

## Key findings

- Patients with acute cholangitis and COVID-19 had significantly longer hospital stays.
- Pseudomonas spp. was more common in the bile cultures of patients with both conditions.
- Malignant causes, particularly pancreatic cancer, were more prevalent in the COVID-19 group.

## Abstract

Background and Objectives: This study aimed to assess the impact of coronavirus disease 2019 (COVID-19) on patients with acute cholangitis (AC) by comparing outcomes, complications, and hospital stays in a tertiary Gastroenterology department. Materials and Methods: This retrospective observational cohort study was conducted in a tertiary gastroenterology department, collecting data from all AC and AC + COVID-19 patients between April 2020 and February 2022. Data included clinical and demographic information, COVID-19-specific details, acute cholangitis presentation, medical records, laboratory results, and interventions. AC was diagnosed using Tokyo Guidelines 2018 (TG18) criteria, with all patients undergoing bile culture sampling. Results: The study included 241 patients, 30 in the COVID group and 211 in the non-COVID group. The COVID group’s mean age was significantly higher (74.3 vs. 67.3 years, p < 0.009). Abdominal pain was more common in the COVID group (90% vs. 70.6%, p < 0.025). Length of hospital stay was longer for COVID patients (13.5 vs. 7.9 days, p < 0.001). COVID patients had higher incidences of malignant causes of AC, with pancreatic cancer being the most common (30%). Pseudomonas spp. was significantly more prevalent in COVID patients (16.7% vs. 5.7%, p = 0.028). Conclusions: Our study results show that COVID-19 affected the duration of hospitalization for patients with AC. Furthermore, this study presents observations regarding the impact of COVID-19 on AC, revealing differences in microbial profiles.

## Linked entities

- **Diseases:** coronavirus disease 2019 (MONDO:0100096), acute cholangitis (MONDO:0001930), pancreatic cancer (MONDO:0005192)

## Full-text entities

- **Diseases:** AC (MESH:D000208), Abdominal pain (MESH:D015746), COVID (MESH:D000086382), pancreatic cancer (MESH:D010190)
- **Species:** Homo sapiens (human, species) [taxon 9606]

---
Source: https://tomesphere.com/paper/PMC11356513